Table 1 Baseline characteristics of survey participants (N = 124)
From: Beyond clinical outcomes: the social and healthcare system implications of hepatitis C treatment
Characteristics | % |
|---|---|
Age, years | |
18–29 | 2 |
30–44 | 30 |
45–60 | 64 |
> 60 | 5 |
Sex | |
Male | 75 |
Female | 25 |
Year HCV diagnosis was received | |
Before 1999 | 40 |
1999–2003 | 15 |
2004–2008 | 18 |
2009–2013 | 13 |
2014–2018 | 15 |
Comorbidities (more than one could be selected) | |
HBV | 13 |
HIV | 24 |
Cardiovascular disease | 7 |
Diabetes | 2 |
Other | 13 |
Currently injecting drugs | |
≥ once a week | 17 |
< once a week | 17 |
No longer injecting | 66 |
Use of opioids/stimulants at start of HCV treatment | |
Users | 65 |
Non-users | 34 |
Did not remember | 1 |
Substances used | |
Opioids (e.g. heroin, morphine) | 92 |
Stimulants (e.g. cocaine, amphetatmine) | 85 |
Both opioids and stimulants | 78 |
Other substances | 58 |
Country | |
UK | 16 |
Germany | 16 |
France | 16 |
Italy | 16 |
Spain | 16 |
Portugal | 12 |
Switzerland | 7 |
Recruitment channel | |
Patient association/organisation | 62 |
HCP referral | 20 |
Recruiter panel | 13 |
Patient referral | 3 |
Online campaign | 2 |
Year started most recent HCV treatment | |
≥ 5 years ago | 8 |
4 years ago | 5 |
3 years ago | 10 |
2 years ago | 19 |
1 year ago | 33 |
This year | 26 |
Where most recent HCV treatment was received | |
Secondary care/hospital | 73 |
Addiction clinic | 14 |
GP/PCP | 5 |
Prison | 2 |
Other | 3 |
HCV treatment most recently receiveda (more than one could be selected) | |
SOF/VEL | 27 |
LDV/SOF | 23 |
SOF | 14 |
GLE/PIB | 6 |
DCV | 5 |
EBR/GZR | 2 |
TEL | 2 |
SOF/VEL/VOX | 2 |
OBV/PTV/r | 2 |
DSV | 2 |
BOC | 2 |
Other/unknown | 23 |